Dr. Reddy's Laboratories Ltd. (RDY)
13.35
-0.33
(-2.41%)
USD |
NYSE |
Jan 08, 16:00
13.37
+0.02
(+0.15%)
After-Hours: 20:00
Dr. Reddy's Laboratories EPS Diluted (Quarterly): 0.1972 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Esperion Therapeutics, Inc. | -0.1561 |
| Concord Medical Services Holdings Ltd. | -- |
| Zai Lab Ltd. | -0.3267 |
| Infosys Ltd. | 0.2031 |
| Novo Nordisk A/S | 0.7044 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 163.39M |
| Revenue (Quarterly) | 1.008B |
| Total Expenses (Quarterly) | 843.76M |
| Enterprise Value | 11.03B |
| Gross Profit Margin (Quarterly) | 51.32% |
| Profit Margin (Quarterly) | 16.20% |
| Earnings Yield | 6.12% |
| Operating Earnings Yield | 6.87% |
| Normalized Earnings Yield | 6.222 |